Genedrive Share Discussion Threads

[eggbaconandbubble] 06/9/2024 08:35

SICO - you do post some good stuff from time to time, but it's always a case of sorting the wheat from the chaff!!!

[eggbaconandbubble] 06/9/2024 08:33

That is what really get my goat!

The 250,000 trade at 09.15.28 was a 'buy' trade. Not a 'sell'.

[z1co] 06/9/2024 08:18

Batti

Posting LIES on the other FRED , he's so pathetic.

The company raised £6m gross only towards the end of May 2024.

Batti , should be ashamed of himself for LYING

[batiatus] 06/9/2024 08:11

Cheek is like a pilot who have abandoned his post with passengers still on the plane.

Would anyone want to board the GDR journey with such turbulence in the management and the SP

[z1co] 06/9/2024 08:03

Contract news next week ???

[batiatus] 06/9/2024 08:03

GDR monthly cash burn is £400-600K

But they only make £100k per year

Not a lie!

Placing likely around the corner

[hazl] 06/9/2024 07:57

I see that Balal H ussain
our new Field Service Engineer has a Linked in page...can anyone here provide more detail?


Balal Hussain - Field Services Engineer - genedrive
LinkedIn · Balal Hussain
320+ followers
Bradford, England, United Kingdom · Field Services Engineer · genedrive
Experience · genedrive Graphic. Field Services Engineer. genedrive. Jul 2024 - Present 2 months · Stockport NHS Foundation Trust. 4 years 10 months.

[z1co] 06/9/2024 07:57

Saad112

I say keep moderating the LIARS and derampers

[socionomics] 06/9/2024 07:51

Here we go!

[hazl] 06/9/2024 07:48

Yes Saad.


Everyone shows their personality on these boards.
You have to get beyond that and look at the facts as best we can.
I liked the first part of his post though.
Anyone that invents a cutting edge technology before the 'big boys' deserves recognition and a salary that reflects that more than some of these people working in banks if you ask me...as long as it doesn't bankrupt the company!

[clem h fandango] 06/9/2024 07:48

Can't disagree with that! Who cares about what went on over the past years, it's a different beast now. Meaningful sales is what will drive the price.But that won't come about from people repeating "2 world class products" on here ad-nausea. In the current lull of news it might keep things cleaner. As discussed having 2 world class products is a key driver for growth, how that translates to shareholder value is yet unseen.

[z1co] 06/9/2024 07:47

MM's giving above MID price for more than half a million shares.

[clem h fandango] 06/9/2024 07:32

Much lower volume start by the looks.So in a Goldilocks scenario, we had too hot (after news hitting 5p), then a little too cold (the preceding drop to 2p), and now have hit where the balance is betwixt buyers and sellers.Next news will drive this upwards, much more chance of a positive announcement than a negative one in the short term.I don't think some of the points were overly negative this morning. A boss on half a million for a loss making company is obscene quite frankly.

[themachine2] 06/9/2024 07:28

At last a decent thread to post your comments!

[themachine2] 06/9/2024 07:22

Saad

These derampers have no shame what so ever.The company has 2 life changing products approved by NICE which will save 1000's of life's and are on the cusp of generating meaningful sales and yet these idiots are still posting garbage.

They will disappear when we get news of further contract wins.

[hazl] 06/9/2024 07:13

When contracts appear they will be gone saad.

[saad112] 06/9/2024 06:59

Prospects for the company have never been better.

Two exceptional tests approved and being used in hospitals.The company is fully funded
Ramp up of tests will start from next year and the company will become EBITDA positive in 2026.

Valued at just £12m with around £5m cash and you still get posters like washingmachine with personal agendas posting rubbish.

[z1co] 06/9/2024 06:25

US market is massive relative to UK and EU:

Genedrive intends to pursue the FDA De Novo regulatory pathway for entry into the U.S. market. The FDA De Novo pathway provides a vehicle for establishing new predicate devices that can reflect modern standards for performance and safety and can serve as a basis for future clearances. De Novo classification is a risk-based classification process used when there is a lack of a predicate device already cleared by the FDA.

In 2021, 3.7 million babies were born in the USA, with 10.5% born prematurely. It was estimated that malpractice litigation settlements in cases related to deafness caused by the use of aminoglycosides average over US$1.1 million per case, further adding to the positive health economic case of providing accurate and timely testing to reduce unwanted side effects of gentamicin usage. Extrapolating from UK figures, the Company estimates that approximately 1,000 babies per annum in U.S. Neonatal Intensive Care Units ("NICU") are at risk of aminoglycoside induced hearing loss.

[batiatus] 05/9/2024 22:52

firestorm's short and long targets:

GEX: short to 6p (didn't happen) He ended up buying in at 11p

GDR: long to 5p when he declared yesterday and said the rise had begun (the price dropped today)

King of farce!